Market Overview:
The global pruritus drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of pruritus, rising awareness about available treatment options, and growing demand for effective therapies. Based on type, the global pruritus drugs market is segmented into topical, oral, and parenteral drugs. The topical segment is expected to account for the largest share of the global market in 2018. This segment is further divided into local and systemic therapies. Local therapies are those that are applied directly to the skin or mucous membranes while systemic therapies are administered orally or through injection or infusion. The oral segment is expected to grow at a higher CAGR than other segments during the forecast period owing to its high efficacy and safety profile as compared with other drug delivery routes. Based on application, hematologic pruritus accounts for the largest share of the global pruritis drugs market followed by oncological pruritus.
Product Definition:
Pruritus is a medical term for itching. There are many causes of pruritus, including skin conditions, systemic diseases, and medications.
Topical:
Topical drugs are used to treat pruritus (itching or scratching) and has been increasingly used in the last decade. The global market for topical drugs was valued at over USD 1 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. Increasing prevalence of diseases such as psoriasis, eczema, dermatitis, urticaria along with rising awareness among patients is expected to drive growth during the forecast period.
Oral:
Oral is a form of drug delivery which involves the administration of drugs in the form of tablets or capsules. The most common route of oral drug delivery is through the mouth. Other routes include nasal, rectal and intravenous (through vein). Drug molecules can be administered as pure forms or they can be mixed with other active ingredients to enhance their activity and potency.
Application Insights:
Based on the application, the global market is segmented into hematologic pruritus, oncological pruritus, renal Pruritus, endocrine pruritus cholestatic Pruritis. The hematologic category dominated the overall market in terms of revenue share in 2017 and is anticipated to continue its dominance over the forecast period. This can be attributed to increasing cancer cases globally and rising awareness about early diagnosis & treatment which eventually leads to higher adoption of drug for treating various types of cancers including skin cancer.
The other category such as diabetic foot ulcers or pressure ulcers accounted for a relatively smaller share as compared with others due to high availability & adoption of parenteral drugs for their treatment.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing regional market over the forecast period. The growth of this region can be attributed to increasing awareness about pruritus treatment options, rising disposable income, and demand for effective yet inexpensive drugs. In addition, growing healthcare infrastructure in emerging countries such as China and India are expected to boost market growth in Asia Pacific region.
In 2016, Japan was one of the largest markets for global pruritus drugs with a revenue share of around 9%. Rising prevalence coupled with high purchasing power is anticipated to drive demand from 2017 through 2030. Moreover Prilosec OTC sales increased by 6% annually between 2012 and 2016 among individuals aged 40 years & above which further supports its usage among adults suffering from on-going itching condition (Japan Food Chemical Research Foundation).
North America accounted for a significant share owing to presence of key players such as Actavis Inc.
Growth Factors:
- Increasing prevalence of skin diseases and disorders: The increasing prevalence of various skin diseases and disorders is one of the key growth drivers for the pruritus drugs market. According to a study by the World Health Organization (WHO), over 1.5 billion people are affected by some form of dermatological disorder, which is likely to increase in future owing to changing lifestyles and environmental factors. This is expected to create significant demand for pruritus drugs in the coming years.
- Rising awareness about available treatment options: There has been a rise in awareness about available treatment options for pruritus among patients in recent years. This has led to an increase in demand for pruritus drugs, as patients are now more willing to seek medical help for their condition.
- Technological advancements: The development of novel technologies such as targeted drug delivery systems has helped improve the efficacy and safety profile of pruritus drugs, thus driving market growth. Additionally, growing investments by pharmaceutical companies into research and development activities aimed at developing new therapies for treating pruritis is also propelling market growth..
Scope Of The Report
Report Attributes
Report Details
Report Title
Pruritus Drugs Market Research Report
By Type
Topical, Oral, Parenteral
By Application
Hematologic Pruritus, Oncological Pruritus, Renal Pruritus, Endocrine Pruritus, Cholestatic Pruritus
By Companies
Allergan Plc, Astellas Pharma Inc., GlaxoSmithKline Plc, Pfizer Inc., Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Pruritus Drugs Market Report Segments:
The global Pruritus Drugs market is segmented on the basis of:
Types
Topical, Oral, Parenteral
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hematologic Pruritus, Oncological Pruritus, Renal Pruritus, Endocrine Pruritus, Cholestatic Pruritus
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan Plc
- Astellas Pharma Inc.
- GlaxoSmithKline Plc
- Pfizer Inc.
- Sanofi
Highlights of The Pruritus Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Topical
- Oral
- Parenteral
- By Application:
- Hematologic Pruritus
- Oncological Pruritus
- Renal Pruritus
- Endocrine Pruritus
- Cholestatic Pruritus
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pruritus Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pruritus drugs are medications that help to relieve itching. They can be used in various forms, including creams, ointments, and pills.
Some of the major players in the pruritus drugs market are Allergan Plc, Astellas Pharma Inc., GlaxoSmithKline Plc, Pfizer Inc., Sanofi.
The pruritus drugs market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pruritus Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pruritus Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pruritus Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pruritus Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pruritus Drugs Market Size & Forecast, 2018-2028
4.5.1 Pruritus Drugs Market Size and Y-o-Y Growth
4.5.2 Pruritus Drugs Market Absolute $ Opportunity
Chapter 5 Global Pruritus Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pruritus Drugs Market Size Forecast by Type
5.2.1 Topical
5.2.2 Oral
5.2.3 Parenteral
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pruritus Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pruritus Drugs Market Size Forecast by Applications
6.2.1 Hematologic Pruritus
6.2.2 Oncological Pruritus
6.2.3 Renal Pruritus
6.2.4 Endocrine Pruritus
6.2.5 Cholestatic Pruritus
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pruritus Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pruritus Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pruritus Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Pruritus Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pruritus Drugs Market Size Forecast by Type
9.6.1 Topical
9.6.2 Oral
9.6.3 Parenteral
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pruritus Drugs Market Size Forecast by Applications
9.10.1 Hematologic Pruritus
9.10.2 Oncological Pruritus
9.10.3 Renal Pruritus
9.10.4 Endocrine Pruritus
9.10.5 Cholestatic Pruritus
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pruritus Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Pruritus Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pruritus Drugs Market Size Forecast by Type
10.6.1 Topical
10.6.2 Oral
10.6.3 Parenteral
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pruritus Drugs Market Size Forecast by Applications
10.10.1 Hematologic Pruritus
10.10.2 Oncological Pruritus
10.10.3 Renal Pruritus
10.10.4 Endocrine Pruritus
10.10.5 Cholestatic Pruritus
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pruritus Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pruritus Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pruritus Drugs Market Size Forecast by Type
11.6.1 Topical
11.6.2 Oral
11.6.3 Parenteral
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pruritus Drugs Market Size Forecast by Applications
11.10.1 Hematologic Pruritus
11.10.2 Oncological Pruritus
11.10.3 Renal Pruritus
11.10.4 Endocrine Pruritus
11.10.5 Cholestatic Pruritus
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pruritus Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Pruritus Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pruritus Drugs Market Size Forecast by Type
12.6.1 Topical
12.6.2 Oral
12.6.3 Parenteral
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pruritus Drugs Market Size Forecast by Applications
12.10.1 Hematologic Pruritus
12.10.2 Oncological Pruritus
12.10.3 Renal Pruritus
12.10.4 Endocrine Pruritus
12.10.5 Cholestatic Pruritus
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pruritus Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pruritus Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pruritus Drugs Market Size Forecast by Type
13.6.1 Topical
13.6.2 Oral
13.6.3 Parenteral
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pruritus Drugs Market Size Forecast by Applications
13.10.1 Hematologic Pruritus
13.10.2 Oncological Pruritus
13.10.3 Renal Pruritus
13.10.4 Endocrine Pruritus
13.10.5 Cholestatic Pruritus
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pruritus Drugs Market: Competitive Dashboard
14.2 Global Pruritus Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan Plc
14.3.2 Astellas Pharma Inc.
14.3.3 GlaxoSmithKline Plc
14.3.4 Pfizer Inc.
14.3.5 Sanofi
